Filed with ASX · · 14 pages · English
Elixinol Wellness Ltd has released its quarterly activities and cash flow report for the third quarter of the fiscal year, highlighting significant growth in sales and gross profit compared to the previous year. The report indicates a positive trend with a notable increase in gross margin and a reduction in operating expenses, reflecting the company's focus on higher-margin products and efficient cost management. Additionally, the company has completed the divestment of its US business and signed an agreement to acquire Vitable, aiming to enhance its operations in the Australian market. Overall, the report emphasizes the company's commitment to building a focused and scalable health and wellness business in Australia.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
1.Revenue for the current Elixinol Wellness Ltd continuing Australia business following the strategic transformation and portfolio restructuring, excluding the recently divested US CBD operations. Results are unaudited. 2.Underlying operating cash excludes ?nancing costs, payments for income taxes...
Follow Elixinol Wellness into a list and get an email when it puts out news.
Follow Elixinol Wellness